shareholders. . According to the previous announcement, after the transferred assets are received, the personnel will follow the principle of "
Yangzi Petrochemical Engineering Company established a subsidiary to explore the path of digital transformation
Time of Update: 2022-06-21
In addition, this system has simple design >The birth of the " Supervision Eye Expert System " has improved the quality and efficiency of supervision work, opened up the road to supervision informatization, and can better serve the owners.
What impact will the medical device classification catalogue in 2022 have on medical device companies?
Time of Update: 2022-06-20
It is worth noting: Medical dressings, medical cold compresses, also known as facial cold compresses, according to the old "Medical Device Classification Catalog", these products are managed as first-class medical devices .
Termination of the acquisition of shares in the German company Neway to force the valve market
Time of Update: 2022-06-18
【Chemical Machinery Equipment Network Star Enterprise ] On September 17, Neway issued an announcement stating that the company had terminated the acquisition of 100% equity of Econosto Internationa l Holding (Deutschland) GmbH (hereinafter referred to as the "target company").
In the second half of the industry, what will innovative pharmaceutical companies bet on tomorrow?
Time of Update: 2022-06-16
With the release of the annual reports of various pharmaceutical companies this year, Junshi relies on the new crown monoclonal antibody to greatly compensate for the lack of performance growth of the core product PD-1 in several Biotechs .
IPO Inventory of Chinese biopharmaceutical companies in 2021
Time of Update: 2022-06-16
7 billion yuan on the Science and Technology Innovation Board); 24 were listed in Hong Kong, China, raising 56.
The wave of layoffs in multinational pharmaceutical companies is coming
Time of Update: 2022-06-16
In addition, according to the official account of Medical Cube invest, Huizhi, Merck, and GSK will reduce the number of employees by more than 5,000 in 2021 .
The semi-annual report of the five major listed power generation companies: fuel costs drop and profits increase simultaneously
Time of Update: 2022-06-16
exceeded institutional expectations, and their stock prices rose sharply following their performance disclosures. Securities research reports and performance announcements of various companies pointed out that the decline in fuel
Toyo Ink Europe Specialty Chemicals Co., Ltd. develops near-infrared sortable black masterbatch
Time of Update: 2022-06-16
The company has recently developed a new series of Lioplax black plastic masterbatches for near-infrared (NIR) separation and subsequent material recycling .
Fengshan Group's announcement on the company's investment in the construction of a production base for fine chemical products and pesticide intermediates
Time of Update: 2022-06-15
in the Construction of a Production Base for Fine Chemical Products and Pesticide Intermediates", it is planned to purchase land and invest in the construction of pesticide and fine chemical product projects in Xinqiao Park of Guang’an Economic and Technological
The TOP20 global pharmaceutical companies are reshuffled!
Time of Update: 2022-06-15
In addition, Pfizer also expects total revenue of about $100 billion in 2022, half of which will come from the new crown vaccine Comirnaty and the oral new crown drug Paxlovid .
WuXi is a dominant company, how does the local biopharmaceutical CDMO walk out of the differentiated route?
Time of Update: 2022-06-15
>. According to the Frost & Sullivan report, from 2016 to 2020, the global biopharmaceutical market will grow from US$220. 2 billion to US$297. 9 billion, with a compound annual growth rate of 7.
Commercialization test transcript: 34 18A pharmaceutical companies have revenue of 25.3 billion yuan and 60% have experienced market value shrinkage
Time of Update: 2022-06-14
In addition to BeiGene, six pharmaceutical companies including Zai Lab, Innovent Bio, Junshi Bio, Clover Bio, Kangfang Bio, and Henlius have invested more than 1 billion yuan in research and development in the past year .
The top BioPharma commercialization test transcript: 34 18A pharmaceutical companies have a revenue of 25.3 billion yuan!
Time of Update: 2022-06-13
In addition to BeiGene, six pharmaceutical companies including Zai Lab, Innovent Bio, Junshi Bio, Clover Bio, Kangfang Bio, and Henlius have invested more than 1 billion yuan in research and development in the past year .
A batch of pharmaceutical machinery companies are pushing forward the project construction at full speed. What signals are they releasing?
Time of Update: 2022-06-12
Concluding remarks Concluding remarks In general, the projects promoted by pharmaceutical machinery companies this year mainly focus on technological innovation and upgrading, expanding production scale, and accelerating intelligent transformation.
China's top 500 foreign trade companies are released: the export roadmap of chemical products announced
Time of Update: 2022-06-10
China Petroleum & Chemical Corporation continued to rank first among the 500 comprehensive foreign trade enterprises, with a total trade volume of 114.
Three landscape lighting-related companies sprint for IPO, these two have successfully listed
Time of Update: 2022-06-10
This public offering of Aike shares plans to raise 845 million yuan to invest in LED landscape lighting fixtures and smart controller production projects, smart research institute construction projects, and supplementary working capital.
Innovative pharmaceutical companies have built their own factories, and the opportunity for pharmaceutical machinery companies is here
Time of Update: 2022-06-10
【Star Enterprise of Chemical Machinery and Equipment Network ] In recent years, with the support of national policies and the booming trend of the biopharmaceutical market, the domestic innovative medicine industry has begun to accelerate its development.